Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

New target identified for acetaminophen liver injury

June 14, 2021

NIDA studies TRV-734 in phase II for opioid use disorder

May 31, 2021

FDA clears IND for Lyndra's LYN-014 for weekly treatment of opioid use disorder

May 7, 2021

FDA approves Kloxxado for opioid overdose

May 4, 2021

Cybin targets IND filing for CYB-003 for alcohol use disorder by year-end

April 27, 2021

InterveXion reports phase II data on IXT-m200 in methamphetamine use disorder

April 20, 2021

FDA approves new expanded indication for Anavip

April 7, 2021

First subjects dosed in study comparing nasal nalmefene with nasal naloxone

April 6, 2021

Primary safety endpoint met in phase Ib/II study of BXCL-501 to treat opioid withdrawal symptoms

April 1, 2021

Brain cell alcohol metabolism affects behavior, addiction

March 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...